Skip to main content
. 2021 Dec 6;36(1):27–39. doi: 10.1007/s40259-021-00508-4

Table.4.

Implementation strategy factors and the weighted median cumulative incidence of patients retransitioning

Characteristic Studies, n
(n = 37)
Patients, n
(n = 8555)
Median cumulative incidence of patients retransitioninga
Manner of providing information
 Both written and verbal information from HCP 13 1918 19.4 (6.7–19.7)
 Written information 1 758 9.9
 Verbal information from HCP 6 590 4.7 (0.5–25.7)
 Not reported 17 5289 7.4 (3.6–15.2)
Training of HCPs
 Both educational and communication 2 670 2.7 (2.7–2.9)
 Educational 4 315 6.8 (1.4–33.4)
 Communication 1 89 25.8 (NA)
 Not reported 30 7481 7.1 (5.2–10.1)
Type of consent
 Informed consent 13 2189 1.6 (1.4–7.6)
 Opt in 9 2030 9.0 (3.4–24.3)
 Opt out 3 1838 9.7 (5.0–13.1)
 Not reported 12 2498 7.4 (5.3–16.0)
Gainsharing
 Yes 2 256 1.4 (1.4–1.5)
 No 0 0
 Not reported 35 8299 7.2 (5.4–17.2)
Option offered to retransition
 Yes 5 463 11.1 (4.1–20.0)
 No 0 0
 Not reported 32 8092 7.0 (5.3–7.8)
Extra control visits
 Yes 14 1473 5.4 (1.6–17.5)
 No 16 4690 7.1 (6.8–27.8)
 Not reported 7 2392 18.3 (9.4–26.0)
Extra laboratory monitoring
 Yes 15 2460 1.6 (2.0–2.7)
 No 12 3320 6.1 (4.8–7.0)
 Not reported 10 2775 5.8 (3.8–13.7)

HCP healthcare professional

aData are presented as weighted % (interquartile range)